Proton therapy is a type of radiation therapy that uses proton beams to treat cancer. It is an advanced form of external beam radiotherapy that enables tumor targeting with minimal radiation exposure to surrounding healthy tissues. Proton therapy provides painless and non-invasive cancer treatment with reduced side effects. This advanced form of radiation therapy effectively treats tumors located close to vital organs and tissues such as the brain, head, neck, prostate, breast, lung, liver, and others. The growing prevalence of cancer paired with rising healthcare expenditure is creating a massive need for proton therapy globally.
The Global Proton Therapy Market is estimated to be valued at US$ 3183.21 Bn in 2024 and is expected to exhibit a CAGR of 13% over the forecast period 2024 To 2031.
Key Takeaways
Key players operating in the Proton Therapy Market are Silicon Labs, Aeotec (formerly Aeon Labs), Fibaro, Qolsys, Zooz, HomeSeer, Leviton, Everspring, Vision Security, and Jasco (GE/Jasco).
The rising prevalence of cancer types treatable with Proton Therapy Market Size worldwide is driving the demand for proton therapy centers. As per WHO projections, the cancer cases are expected to rise by 70% in the next two decades which is anticipated to propel the proton therapy adoption.
Major players are expanding their global footprint to untapped markets in the Asia Pacific, Latin America, and Middle East & Africa. Leading companies are collaborating with hospitals, cancer institutes to establish new proton therapy centers worldwide and drive the market growth.
Market Key Trends
One of the key trends gaining traction in the Proton Therapy Market Size And Trends is the introduction of compact and cost-effective proton therapy systems. Major players are investing in developing novel proton therapy technologies using advanced particle accelerators, scanning nozzles, and imaging systems to build smaller and affordable proton therapy centers. This is anticipated to make proton therapy accessible to more patients globally over the forecast period.
Porter’s Analysis
Threat of new entrants: High capital requirements and need for specialized expertise pose barriers for new companies entering the proton therapy market.
Bargaining power of buyers: Individual consumers have low bargaining power as they need proton therapy for cancer treatment. However, large healthcare providers and insurance companies can negotiate on pricing and influence market trends.
Bargaining power of suppliers: A few major companies dominate the supply of key components like cyclotrons and delivery systems used in proton therapy. This gives them significant influence over pricing.
Threat of new substitutes: While photon radiation continues to be a standard cancer treatment option, proton therapy offers localized dose distribution with comparatively less side effects. Limited alternatives provide some cushion.
Competitive rivalry: The proton therapy market sees intense competition among key global players. Players compete based on technology advancements, geographic expansion, and partnerships with hospitals and cancer care centers.
Geographical Regions
North America currently holds the largest share of the proton therapy market, mainly due to the presence of major players and advances clinical infrastructure. The United States alone accounts for over 50% of the global proton therapy centers.
The Asia Pacific region is witnessing the fastest growth and offers lucrative opportunities. This is attributed to factors like growing cancer prevalence, increasing healthcare investments, and expanding medical tourism across countries like China, India and Japan.
*Note:
1. Source: Coherent Market Insights, Public Source, Desk Research
2. We have leveraged AI tools to mine information and compile it
About Author - Money Singh
Money Singh is a seasoned content writer with over four years of experience in the market research sector. Her expertise spans various industries, including food and beverages, biotechnology, chemicals and materials, defense and aerospace, consumer goods, etc. LinkedIn Profile